This phase 2b/3 trial follows new, positive 2-year data from the phase 2 ALTITUDE trial, in which sura-vec was well-tolerated ...

LEAP TA: Life Sciences is the only event entirely dedicated to transforming how biotech and pharma organizations are ...

The new North Chicago facility, slated to open in 2027, will boost domestic production of key drug ingredients for immunology ...